Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000559096 | SCV000629319 | benign | Retinoblastoma | 2024-04-23 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV000763897 | SCV000894833 | uncertain significance | Bone osteosarcoma; Malignant tumor of urinary bladder; Small cell lung carcinoma; Retinoblastoma | 2018-10-31 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002438313 | SCV002745369 | benign | Hereditary cancer-predisposing syndrome | 2024-04-27 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Baylor Genetics | RCV003470733 | SCV004208535 | uncertain significance | Malignant tumor of urinary bladder | 2023-06-30 | criteria provided, single submitter | clinical testing | |
Gene |
RCV004772957 | SCV005383213 | uncertain significance | not provided | 2024-01-22 | criteria provided, single submitter | clinical testing | Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge; This variant is associated with the following publications: (PMID: 23516486) |